COOPERMAN DANIEL
Known title: DirectorCIK: 0001205008
Associated companies
Transaction History
| MOH | ▲ Buy | Grant | 56 | $18K | 4/1/2025 | View on chart |
| MOH | ▲ Buy | Grant | 189 | $55K | 1/1/2025 | View on chart |
| MOH | ▲ Buy | Grant | 161 | $55K | 10/1/2024 | View on chart |
| MOH | ▲ Buy | Grant | 188 | $55K | 7/1/2024 | View on chart |
| MOH | ▲ Buy | Grant | 136 | $55K | 4/1/2024 | View on chart |
| MOH | ▲ Buy | Grant | 152 | $55K | 1/1/2024 | View on chart |
| MOH | ▲ Buy | Grant | 168 | $55K | 10/1/2023 | View on chart |
| MOH | ▲ Buy | Grant | 183 | $55K | 7/1/2023 | View on chart |
| MOH | ▲ Buy | Grant | 206 | $55K | 4/1/2023 | View on chart |
| MOH | ▲ Buy | Option Exercise | 5,000 | $165K | 3/3/2023 | View on chart |
| MOH | ▼ Sell | Open Market | 5,000 | $1.4M | 3/3/2023 | View on chart |
| MOH | ▲ Buy | Grant | 167 | $55K | 1/1/2023 | View on chart |
| MOH | ▲ Buy | Grant | 167 | $55K | 10/1/2022 | View on chart |
| MOH | ▲ Buy | Option Exercise | 2,500 | $83K | 9/8/2022 | View on chart |
| MOH | ▼ Sell | Open Market | 2,500 | $883K | 9/8/2022 | View on chart |
| MOH | ▲ Buy | Option Exercise | 2,500 | $83K | 9/7/2022 | View on chart |
| MOH | ▼ Sell | Open Market | 2,500 | $865K | 9/7/2022 | View on chart |
| MOH | ▲ Buy | Grant | 194 | $55K | 7/1/2022 | View on chart |
| MOH | ▲ Buy | Grant | 162 | $55K | 4/1/2022 | View on chart |
| MOH | ▲ Buy | Grant | 173 | $55K | 1/1/2022 | View on chart |
| MOH | ▲ Buy | Option Exercise | 5,000 | $165K | 11/15/2021 | View on chart |
| MOH | ▼ Sell | Open Market | 5,000 | $1.5M | 11/15/2021 | View on chart |
| MOH | ▲ Buy | Grant | 203 | $55K | 10/1/2021 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 5, 2026
Molina Healthcare Draws Value Investor Interest Amid Recent Pressure
Diamond Hill Capital has highlighted long-term value in Molina Healthcare following recent stock price pressure. This view is echoed by other market analyses questioning if the stock is a value play. The company is currently trading near its 52-week low, with an average analyst target of $209.12.
Molina Healthcare Draws Value Investor Interest Amid Recent Pressure. Diamond Hill Capital has highlighted long-term value in Molina Healthcare following recent stock price pressure. This view is echoed by other market analyses questioning if the stock is a value play. The company is currently trading near its 52-week low, with an average analyst target of $209.12.